Categorías
-
Adhesives
6
Amines
99
Amino Acids
183
Analytical Reagents
702
Antibiotics
254
Bioactive Small Molecules
739
Aroma Chemicals
212
Biochemicals
1041
Boronic Acids
4
Buffers
97
Building Blocks
1909
Carbohydrates
179
Catalysts
108
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
261
Flavours and Fragrance Materials
213
Fluorinated Products
50
Furans
6
Gases in Solution
48
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
341
Ion-Pair Reagents
23
Ligands
80
Organics
1424
Oxazoles
3
Peptide Reagents
90
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
107
Research Organics & Inorganics
797
Salts
296
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
301
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
49
Water Analysis
12
Dexamethasone
(16320764 | 50-02-2)
CAS: | 50-02-2 |
---|---|
Fórmula molecular: | C22H29FO5 |
Peso molecular: | 392.46 |
Disponibilidad: | En stock |
---|---|
Descargas: | | |
16320764-1g | 1g | £45.30 | |
Pedido bulk |
16320764-1g | 1g | €63.50 | |
Pedido bulk |
16320764-1g | 1g | $68.00 | |
Pedido bulk |
Ficha de datos de seguridad
Certificado de análisis
Detalle del producto
Product Code | 16320764 | ||||
Product Name | Dexamethasone | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 50-02-2 | ||||
Molecular Formula | C22H29FO5 | ||||
Molecular Weight | 392.46 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2937220000 |
Especificaciones del producto
Grade | EP 6.0 | ||||
Specific rotation | +75 to +80 | ||||
Loss on Drying | 0.5% max | ||||
Assay | 97.0% - 103.0% | ||||
Organic Volatile Impurities | meets the requirements | ||||
Appearance | White or almost white crystalline powder | ||||
Any individual impurity | 0.5% max | ||||
Total Impurites | 1.0% max |
Información de seguridad
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|